Per Jynge
Overview
Explore the profile of Per Jynge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Karlsson J, Jynge P
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38673932
Platinum-containing chemotherapeutic drugs are efficacious in many forms of cancer but are dose-restricted by serious side effects, of which peripheral neuropathy induced by oxidative-nitrosative-stress-mediated chain reactions is most disturbing. Recently,...
3.
Karlsson J, Jynge P, Ignarro L
Antioxidants (Basel)
. 2023 Mar;
12(3).
PMID: 36978857
Disappointing results from the POLAR A and M phase III trials involving colorectal cancer patients on chemotherapy with FOLFOX6 in curative (A) and palliative (M) settings have been reported by...
4.
Karlsson J, Jynge P, Ignarro L
Antioxidants (Basel)
. 2021 Dec;
10(12).
PMID: 34943040
On 2 July 2021, highly negative results were reported from the POLAR A and M phase III trials in patients with colorectal cancer, treated with an oxaliplatin-based regimen and co-treated...
5.
Karlsson J, Jynge P, Ignarro L
Antioxidants (Basel)
. 2020 Oct;
9(10).
PMID: 33050459
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by massive inflammation of the arterial endothelium accompanied by vasoconstriction and widespread pulmonary micro thrombi. As a result, due to the...
6.
Jynge P, Skjold A, Falkmer U, Andersson R, Seland J, Bruvold M, et al.
Contrast Media Mol Imaging
. 2020 Sep;
2020:3262835.
PMID: 32994754
The semistable chelate manganese (Mn) dipyridoxyl diphosphate (MnDPDP, mangafodipir), previously used as an intravenous (i.v.) contrast agent (Teslascan™, GE Healthcare) for Mn-ion-enhanced MRI (MEMRI), should be reappraised for clinical use...
7.
Karlsson J, Jynge P, Lundstrom I, Ignarro L
Trials
. 2019 Jun;
20(1):380.
PMID: 31234946
No abstract available.
8.
9.
Karlsson J, Andersson R, Jynge P
Transl Oncol
. 2017 Jul;
10(4):641-649.
PMID: 28668762
Oxaliplatin, in combination with 5-fluorouracil plus folinate (or capecitabine), has increased survival substantially in stage III colorectal cancer and prolonged life in stage IV patients, but its use is compromised...
10.
Karlsson J, El-Saadi W, Ali M, Puskar W, Skogvard P, Engvall J, et al.
Eur Heart J Cardiovasc Pharmacother
. 2016 Aug;
1(1):39-45.
PMID: 27533964
Aims: The aim of the present study was to examine the feasibility of applying the catalytic antioxidant mangafodipir [MnDPDP, manganese (Mn) dipyridoxyl diphosphate] as a cardioprotective adjunct to primary percutaneous...